NASDAQ: SXTC
China Sxt Pharmaceuticals Inc Stock Ownership - Who owns China Sxt Pharmaceuticals?

Insider buying vs selling

Have China Sxt Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when SXTC insiders and whales buy or sell their stock.

SXTC Shareholders

What type of owners hold China Sxt Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC19.47%150,576$308.68kInstitution
Invesco Ltd11.03%85,331$174.93kInstitution
Geode Capital Management LLC6.94%53,671$110.03kInstitution
Xtx Topco Ltd2.94%22,774$46.69kInstitution
Virtu Financial LLC1.60%12,355$25.33kInstitution
Tower Research Capital LLC Trc0.24%1,827$3.75kInstitution
Royal Bank Of Canada0.11%818$1.68kInstitution
Royal Bank Of Canada 10.11%818$1.68kInstitution
Ubs Group Ag0.03%222$455.10Institution
Feng Felix Zhou0.00%4$8.20Insider

1 of 1

SXTC vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SXTC42.35%0.00%
AKAN85.41%14.59%Net Selling
PRFX7.82%0.00%
IMCC3.04%0.00%
UPC0.17%0.62%

China Sxt Pharmaceuticals Stock Ownership FAQ

Who owns China Sxt Pharmaceuticals?

China Sxt Pharmaceuticals (NASDAQ: SXTC) is owned by 42.35% institutional shareholders, 0.00% China Sxt Pharmaceuticals insiders, and 57.65% retail investors. Feng Felix Zhou is the largest individual China Sxt Pharmaceuticals shareholder, owning 4.00 shares representing 0.00% of the company. Feng Felix Zhou's China Sxt Pharmaceuticals shares are currently valued at $8.24.

If you're new to stock investing, here's how to buy China Sxt Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.